Lupus anticoagulant associates with thrombosis in patients with COVID‐19 admitted to intensive care units: A retrospective cohort study

Autor: Noordermeer, Tessa, Schutgens, Roger E.G., Visser, Chantal, Rademaker, Emma, de Maat, Moniek P.M., Jansen, A.J. Gerard, Limper, Maarten, Cremer, Olaf L., Kruip, Marieke J.H.A., Endeman, Henrik, Maas, Coen, de Laat, Bas, Urbanus, Rolf T. ^*, van de Beek, D., Brouwer, M.C., de Bruin, S., Coppens, M., van Es, N., van Haaps, T.F., Juffermans, N.P., Muller, M.C.A., Vlaar, A.P.J., Hertogh, C.M.P.M., Heunks, L.M.A., Hugtenburg, J.G., van Kooten, J., Nossent, E.J., Smulders, Y., Tuinman, P.R., Vonk Noordegraaf, A., Grootenboers, M.J.J.H., van Guldener, C., Kant, M., Lansbergen, A., Faber, J., Hajer, G., Stemerdink, A., van den Akker, J., Bierings, R., Endeman, H., Goeijenbier, M., Hunfeld, N.G.M., van Gorp, E.C.M., Gommers, D.A.M.P.J., Koopmans, M.P.G., Kruip, M.J.H.A., Kuiken, T., Langerak, T., Leebeek, Lauw, M.N., de Maat, M.P.M., Noack, D., Paats, M.S., Raadsen, M.P., Rockx, B., Rokx, C., Schurink, C.A.M., Tong‐Minh, K., van den Toorn, L., den Uil, C.A., Visser, C., Boutkourt, F., Roest, T., Douma, R.A., de Haan, L.R., ten Wolde, M., Bemelmans, R.H.H., Festen, B., Stads, S., de Jager, C.P.C., Simons, K.S., Antoni, M.L., Bos, M.H., Burggraaf, J.L.I., Cannegieter, S.C., Eikenboom, H.C.J., den Exter, P.L., Geelhoed, J.J.M., Huisman, M.V., de Jonge, E., Kaptein, F.H.J., Klok, F.A., Kroft, L.J.M., Lijfering, W.M., Nab, L., Ninaber, M.K., Putter, H., Ramai, S.R.S., da Rocha Rondon, A.M., Roukens, A.H.E., Stals, M.A.M., Versteeg, H.H., Vliegen, H.W., van Vlijmen, B.J.M., van de Berg, T., Bruggemann, R., van Bussel, B.C.T., ten Cate, H., ten Cate‐Hoek, A., Hackeng, T.M., Henskens, ir.Y., Hulshof, A., Mulder, M., Olie, R.H., Schurgers, L., Spaetgens, B., Spronk, H., Winckers, K., Nieuwenhuizen, L., Franken, B., Schrover, I.M., de Waal, E.G.M., Beishuizen, A., Cornet, A., Krabbe, J., Kramers, K., Leentjens, J., de Mast, Q., Middeldorp, S., Brouwer, R.E., Ellerbroek, J.L.J., Tijmensen, J., Hovens, M.M C., Oostdijk, E.A.N., Westerhof, B.D., Faber, L.M., van den Biggelaar, M., Meijers, J.C.M., Voorberg, J., Kevenaar, M.E., Soei, Y.L., Wils, E.J., Croles, F.N., de Laat, B., Kamphuisen, P.W., Vink, R., Lisman, T., Meijer, K., van Tichelaar, Y.I.G., Cremer, O.L., Geersing, G., Kaasjager, H.A.H., Kusadasi, N., Huisman, A., Maas, C., Nijkeuter, M., Schutgens, R.E.G., Creveldkliniek, Van, Urbanus, R.T., Westerink, J., Faber, H.J., Koster, S.C.E., van Montfort, P., van Twist, D.J.L.

Publikováno v: In Research and Practice in Thrombosis and Haemostasis August 2022 6(6)

Redefining clinical venous thromboembolism phenotypes: a novel approach using latent class analysis

Autor: Winter, M.A. de, Uijl, A., Büller, H.R., Carrier, M., Cohen, A.T., Hansen, J.B., Kaasjager, K.H.A.H., Kakkar, A.K., Middeldorp, S., Raskob, G.E., Sørensen, H.T., Wells, P.S., Nijkeuter, M., Dorresteijn, Jannick A.N.

Publikováno v: de Winter, M A, Uijl, A, Büller, H R, Carrier, M, Cohen, A T, Hansen, J B, Kaasjager, K H A H, Kakkar, A K, Middeldorp, S, Raskob, G E, Sørensen, H T, Wells, P S, Nijkeuter, M & Dorresteijn, J A N 2023, ' Redefining clinical venous thromboembolism phenotypes : a novel approach using latent class analysis ', Journal of thrombosis and haemostasis : JTH, vol. 21, no. 3, pp. 573-585 . https://doi.org/10.1016/j.jtha.2022.11.013
Journal of thrombosis and haemostasis : JTH, 21(3), 573-585. Wiley-Blackwell
de Winter, M A, Uijl, A, Büller, H R, Carrier, M, Cohen, A T, Hansen, J-B, Kaasjager, K H A H, Kakkar, A K, Middeldorp, S, Raskob, G E, Sørensen, H T, Wells, P S, Nijkeuter, M & Dorresteijn, J A N 2023, ' Redefining clinical venous thromboembolism phenotypes : a novel approach using latent class analysis ', Journal of Thrombosis and Haemostasis, vol. 21, no. 3, pp. 573-585 . https://doi.org/10.1016/j.jtha.2022.11.013
Journal of Thrombosis and Haemostasis, 21, 3, pp. 573-585
Journal of Thrombosis and Haemostasis, 21, 573-585

Item does not contain fulltext BACKGROUND: Patients with venous thromboembolism (VTE) are commonly classified by the presence or absence of provoking factors at the time of VTE to guide treatment decisions. This approach may not capture the heterogen

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e9d9151a4d2f3954cfe119de7baad577
https://hdl.handle.net/2066/290893

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Recurrent venous thromboembolism and bleeding with extended anticoagulation: the VTE-PREDICT risk score

Autor: Winter, M.A. de, Büller, H.R., Carrier, M., Cohen, A.T., Hansen, J.B., Kaasjager, Karin A. H., Kakkar, A.K., Middeldorp, S., Raskob, G.E., Sørensen, H.T., Visseren, F.L., Wells, P.S., Dorresteijn, Jannick A.N., Nijkeuter, M.

Publikováno v: European Heart Journal, 44, 1231-1244
European Heart Journal, 44, 14, pp. 1231-1244

Contains fulltext : 291972.pdf (Publisher’s version ) (Open Access) AIMS: Deciding to stop or continue anticoagulation for venous thromboembolism (VTE) after initial treatment is challenging, as individual risks of recurrence and bleeding are heter

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::5412148b6da3f21632ec966b7cc143ca
http://hdl.handle.net/2066/291972

Plasma levels of microparticle-associated tissue factor activity in patients with clinically suspected pulmonary embolism

Autor: Garcia Rodriguez, P., Eikenboom, H.C.J., Tesselaar, M.E.T., Huisman, M.V., Nijkeuter, M., Osanto, S., Bertina, R.M.

Publikováno v: In Thrombosis Research 2010 126(4):345-349